Ausgabe 10/2019
Inhalt (19 Artikel)
Immune checkpoint inhibitor-induced sarcoidosis-like granulomas
Pooja H. Rambhia, Barbara Reichert, Jeffrey F. Scott, Ashley N. Feneran, Jordan A. Kazakov, Kord Honda, Henry Koon, Meg R. Gerstenblith
Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy
Yuichi Kibe, Naoki Nakamura, Hirofumi Kuno, Takashi Hiyama, Ryuichi Hayashi, Sadamoto Zenda, Atsushi Motegi, Hidehiro Hojo, Masaki Nakamura, Takaki Ariji, Hajime Oyoshi, Tetsuo Akimoto
Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer
Kozo Miyatani, Hiroaki Saito, Shota Shimizu, Yusuke Kono, Yuki Murakami, Yuji Shishido, Tomoyuki Matsunaga, Yoji Fukumoto, Yoshiyuki Fujiwara
Systemic chemotherapy for gastric cancer with early recurrence after adjuvant S-1 monotherapy: a multicenter retrospective study
Seiichiro Mitani, Shigenori Kadowaki, Hiroko Hasegawa, Takeru Wakatsuki, Hiroki Hara, Masahiro Tajika, Kazuhiro Nishikawa, Motohiro Hirao, Daisuke Takahari, Keisho Chin, Kei Muro
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A)
Shun Sasaki, Eiji Oki, Hiroshi Saeki, Takayuki Shimose, Sanae Sakamoto, Qingjiang Hu, Kensuke Kudo, Yasuo Tsuda, Yuichiro Nakashima, Koji Ando, Yoshito Akagi, Yoshihiro Kakeji, Hideo Baba, Yoshihiko Maehara
Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
Toshikazu Moriwaki, Yoshinori Sakai, Hiroyasu Ishida, Yoshiyuki Yamamoto, Shinji Endo, Hideaki Kuramochi, Mikio Sato, Yukimasa Hatachi, Yoshiaki Bando, Takashi Maeba, Kazuto Ikezawa, Mitsuo Shimada, Kenji Amagai, Masamitsu Morimoto, Kazuma Kobayashi, Akihito Tsuji, Tomohiro Nishina, Ichinosuke Hyodo
Multicenter phase II study of biweekly CAPIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer (JSWOG-C3 study)
Nobuaki Suzuki, Shoichi Hazama, Takeshi Nagasaka, Hiroaki Tanioka, Yasuo Iwamoto, Yuji Negoro, Masami Yamauchi, Michiya Kobayashi, Hiroshi Okuda, Noriaki Fujishima, Taku Nishimura, Naoki Yamanaka, Kazuhiro Toyota, Yoshiko Mori, Yuki Nakagami, Mototsugu Shimokawa, Hiroaki Nagano, Masazumi Okajima
Prognostic factors and survival in Japanese patients with brain metastasis from renal cell cancer
Nobushige Takeshita, Masafumi Otsuka, Tomohiko Kamasako, Takatoshi Somoto, Toshihiro Uemura, Tetsuo Shinozaki, Masayuki Kobayashi, Hidetada Kawana, Makiko Itami, Toshihiko Iuchi, Atsushi Komaru, Satoshi Fukasawa
Time to biochemical relapse after radical prostatectomy and efficacy of salvage radiotherapy in patients with prostate cancer
Sahyun Pak, Dalsan You, In Gab Jeong, Young Seok Kim, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn
Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation
Rihito Aizawa, Kenji Takayama, Kiyonao Nakamura, Takahiro Inoue, Toshinari Yamasaki, Takashi Kobayashi, Shusuke Akamatsu, Osamu Ogawa, Takashi Mizowaki
Predictors of favorable survival after secondary cytoreductive surgery for recurrent endometrial cancer
Ayumi Shikama, Takeo Minaguchi, Wataru Takao, Yoshihiko Hosokawa, Keiko Nishida, Nobutaka Tasaka, Azusa Akiyama, Manabu Sakurai, Hiroyuki Ochi, Toyomi Satoh
Clinical significance of the pattern-based classification in endocervical adenocarcinoma, usual and variants
Jung Mi Byun, Hwa Jin Cho, Ha Young Park, Young Nam Kim, Kyung Bok Lee, Moon Su Sung, Chul Hoi Jeong, Dae Hoon Jeong
Thrombotic events induce the worse prognosis in ovarian carcinomas and frequently develop in ovarian clear cell carcinoma
Kazuki Takasaki, Morikazu Miyamoto, Masashi Takano, Hiroaki Soyama, Tadashi Aoyama, Hiroko Matsuura, Hideki Iwahashi, Hiroki Ishibashi, Takahiro Sakamoto, Kenichi Furuya
A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study)
Hiroyuki Fujiwara, Kimio Ushijima, Shoji Nagao, Yuji Takei, Muneaki Shimada, Masashi Takano, Kiyoshi Yoshino, Yoshiaki Kawano, Yasuyuki Hirashima, Satoru Nagase, Shin Nishio, Tadaaki Nishikawa, Kimihiko Ito, Tadahiro Shoji, Eizo Kimura, Tadao Takano, Toru Sugiyama, Junzo Kigawa, Keiichi Fujiwara, Mitsuaki Suzuki
Volumetric and texture analysis on FDG PET in evaluating and predicting treatment response and recurrence after chemotherapy in follicular lymphoma
Mitsuaki Tatsumi, Kayako Isohashi, Keiko Matsunaga, Tadashi Watabe, Hiroki Kato, Yuzuru Kanakura, Jun Hatazawa
Clinical significance of prognostic nutritional index (PNI) in malignant melanoma
Cem Mirili, Ali Yılmaz, Serkan Demirkan, Mehmet Bilici, Salim Basol Tekin
Prognostic implication of adjuvant/neoadjuvant chemotherapy consisting of doxorubicin and ifosfamide in patients with extraskeletal osteosarcoma
Toru Wakamatsu, Shigeki Kakunaga, Satoshi Takenaka, Hidetatsu Outani, Kenichiro Hamada, Yoshinori Imura, Yumiko Hori, Norifumi Naka, Ikuo Kudawara, Hideki Yoshikawa, Takafumi Ueda
A single-arm, phase 2 study of steroid-containing mouthwash for the prevention of everolimus-associated stomatitis in multiple tumor types
Masaya Hattori, Sumitaka Hagiwara, Haruru Kotani, Michiko Tatematsu, Masahiko Tachi, Susumu Hijioka, Junichi Shimizu, Masashi Andoh, Yasunari Mizuno, Masataka Sawaki, Akiyo Yoshimura, Naomi Gondo, Yayoi Adachi, Kenichi Yoshimura, Hiroji Iwata
Familial cancer of unknown primary
Elie Rassy, Joseph Kattan, Nicholas Pavlidis